BancorpSouth Bank grew its position in shares of CVS Health Corp (NYSE:CVS) by 2.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 35,373 shares of the pharmacy operator’s stock after buying an additional 834 shares during the quarter. BancorpSouth Bank’s holdings in CVS Health were worth $2,785,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in the company. Buckley Wealth Management LLC lifted its position in shares of CVS Health by 18.2% during the third quarter. Buckley Wealth Management LLC now owns 11,596 shares of the pharmacy operator’s stock worth $913,000 after purchasing an additional 1,783 shares in the last quarter. Alps Advisors Inc. lifted its position in shares of CVS Health by 20.8% during the third quarter. Alps Advisors Inc. now owns 12,944 shares of the pharmacy operator’s stock worth $1,019,000 after purchasing an additional 2,228 shares in the last quarter. Alpha Cubed Investments LLC acquired a new position in shares of CVS Health during the third quarter worth approximately $365,000. Oakworth Capital Inc. lifted its position in shares of CVS Health by 32.1% during the third quarter. Oakworth Capital Inc. now owns 3,097 shares of the pharmacy operator’s stock worth $244,000 after purchasing an additional 752 shares in the last quarter. Finally, Palo Capital Inc. lifted its position in shares of CVS Health by 90.4% during the third quarter. Palo Capital Inc. now owns 60,510 shares of the pharmacy operator’s stock worth $4,763,000 after purchasing an additional 28,729 shares in the last quarter. Institutional investors own 82.56% of the company’s stock.

Shares of NYSE CVS opened at $70.12 on Monday. CVS Health Corp has a fifty-two week low of $60.14 and a fifty-two week high of $83.88. The company has a market capitalization of $71.39 billion, a P/E ratio of 11.88, a price-to-earnings-growth ratio of 0.94 and a beta of 1.02. The company has a current ratio of 2.34, a quick ratio of 1.87 and a debt-to-equity ratio of 1.73.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 8th. The pharmacy operator reported $1.69 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.61 by $0.08. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. The business had revenue of $46.71 billion for the quarter, compared to analyst estimates of $46.34 billion. During the same period in the prior year, the business posted $1.33 earnings per share. CVS Health’s revenue was up 2.2% compared to the same quarter last year. Research analysts predict that CVS Health Corp will post 7.01 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 1st. Investors of record on Wednesday, October 24th will be issued a $0.50 dividend. The ex-dividend date is Tuesday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.85%. CVS Health’s dividend payout ratio is currently 33.90%.

A number of equities analysts have recently issued reports on CVS shares. Tigress Financial reiterated a “buy” rating on shares of CVS Health in a research report on Friday. Royal Bank of Canada reiterated a “buy” rating and set a $90.00 target price on shares of CVS Health in a research report on Wednesday, August 8th. Citigroup reiterated a “buy” rating and set a $81.00 target price on shares of CVS Health in a research report on Monday, July 9th. Bank of America upped their target price on shares of CVS Health from $86.00 to $90.00 and gave the stock a “buy” rating in a research report on Monday, September 17th. Finally, ValuEngine upgraded shares of CVS Health from a “sell” rating to a “hold” rating in a research report on Thursday, October 11th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, ten have given a buy rating and two have issued a strong buy rating to the company’s stock. CVS Health presently has a consensus rating of “Buy” and an average target price of $86.18.

In other CVS Health news, EVP Eva C. Boratto sold 13,311 shares of the stock in a transaction on Monday, September 17th. The shares were sold at an average price of $77.16, for a total value of $1,027,076.76. Following the sale, the executive vice president now directly owns 55,162 shares in the company, valued at $4,256,299.92. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Lisa Bisaccia sold 21,534 shares of the stock in a transaction on Monday, October 1st. The stock was sold at an average price of $80.00, for a total transaction of $1,722,720.00. The disclosure for this sale can be found here. Insiders sold 43,409 shares of company stock worth $3,392,097 over the last 90 days. 0.53% of the stock is currently owned by company insiders.

About CVS Health

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Recommended Story: Put Option

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.